Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -670 | -267 | 4,962 | 3,229 | 1,674 |
| Depreciation Amortization | 5,285 | 2,716 | 10,963 | 8,023 | 5,326 |
| Income taxes - deferred | 551 | 307 | 400 | 282 | 225 |
| Accounts receivable | -8,444 | -1,593 | -5,089 | -2,465 | -1,481 |
| Accounts payable and accrued liabilities | -249 | 183 | 32 | 195 | -282 |
| Other Working Capital | -9,189 | -3,906 | -7,752 | -4,267 | -2,942 |
| Other Operating Activity | 18,640 | 5,637 | 17,897 | 11,586 | 8,130 |
| Operating Cash Flow | $5,924 | $3,077 | $21,413 | $16,583 | $10,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,051 | -1,218 | -2,643 | -1,800 | -960 |
| Net Acquisitions | -531 | N/A | -20,845 | -19,543 | -9,642 |
| Investing Cash Flow | $-2,582 | $-1,218 | $-23,488 | $-21,343 | $-10,602 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 177 | 177 | N/A | 0 | 0 |
| Debt Repayment | -502 | -276 | -1,006 | -745 | -400 |
| Common Stock Issued | 1,505 | 1,172 | 4,861 | 3,946 | 659 |
| Common Stock Repurchased | -2,000 | 0 | -8,590 | -6,235 | -6,235 |
| Financing Cash Flow | $-820 | $1,073 | $-4,735 | $-3,034 | $-5,976 |
| Exchange Rate Effect | -10 | -35 | -219 | -159 | -227 |
| Beginning Cash Position | 43,182 | 43,182 | 50,211 | 50,211 | 50,211 |
| End Cash Position | 45,694 | 46,079 | 43,182 | 42,258 | 44,056 |
| Net Cash Flow | $2,512 | $2,897 | $-7,029 | $-7,953 | $-6,155 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,924 | 3,077 | 21,413 | 16,583 | 10,650 |
| Capital Expenditure | -2,051 | -1,218 | -2,643 | -1,800 | -960 |
| Free Cash Flow | 3,873 | 1,859 | 18,770 | 14,783 | 9,690 |